bf/NASDAQ:FATE_icon.jpeg

COM:FATETHERAPEUTICS

Fate Therapeutics

  • Stock

USD

Last Close

2.07

22/11 21:00

Market Cap

355.16M

Beta: -

Volume Today

652

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
971K
-
2.43M
-
4.40M
81.08%
4.11M
6.72%
4.74M
15.44%
10.68M
125.32%
31.43M
194.33%
55.85M
77.66%
96.30M
72.44%
63.53M
34.03%
cost of revenue
18.28M
-
gross profit
971K
-
2.43M
-
4.40M
81.08%
4.11M
6.72%
4.74M
15.44%
10.68M
125.32%
31.43M
194.33%
55.85M
77.66%
96.30M
72.44%
45.25M
53.01%
selling and marketing expenses
-2M
-
general and administrative expenses
6.64M
-
8.47M
27.56%
10.35M
22.23%
9.91M
4.24%
11.87M
19.77%
15.81M
33.14%
23.64M
49.53%
33.90M
43.40%
57.32M
69.11%
84.23M
46.95%
81.45M
3.31%
selling general and administrative expenses
6.64M
-
8.47M
27.56%
10.35M
22.23%
9.91M
4.24%
11.87M
19.77%
15.81M
33.14%
23.64M
49.53%
33.90M
43.40%
57.32M
69.11%
84.23M
46.95%
79.45M
5.68%
research and development expenses
12.01M
-
16.43M
36.88%
19.86M
20.85%
26.45M
33.19%
34.36M
29.89%
56.02M
63.06%
87.77M
56.67%
125.62M
43.13%
215.52M
71.56%
320.45M
48.69%
143.41M
55.25%
other expenses
20.82M
-
9.88M
52.54%
cost and expenses
18.65M
-
24.90M
33.56%
30.21M
21.32%
36.37M
20.36%
46.23M
27.13%
71.83M
55.38%
111.41M
55.09%
159.52M
43.19%
272.84M
71.04%
404.69M
48.32%
241.14M
40.41%
operating expenses
18.65M
-
24.90M
33.56%
30.21M
21.32%
36.37M
20.36%
46.23M
27.13%
71.83M
55.38%
111.41M
55.09%
159.52M
43.19%
272.84M
71.04%
404.69M
48.32%
222.86M
44.93%
interest expense
796K
-
549K
31.03%
2.22M
304.37%
1.64M
26.26%
1.27M
22.54%
1.70M
33.75%
1.75M
3.30%
5.84M
-
ebitda
-17.10M
-
-24.90M
45.64%
-27.77M
11.53%
-31.82M
14.59%
-41.57M
30.61%
-64.90M
56.14%
-96.40M
48.53%
-125.69M
30.38%
-215.69M
71.61%
-308.39M
42.98%
-159.33M
48.33%
operating income
-17.68M
-
-24.90M
40.90%
-27.78M
11.56%
-31.96M
15.05%
-42.13M
31.79%
-67.09M
59.27%
-100.73M
50.13%
-128.09M
27.16%
-216.99M
69.41%
-308.39M
42.12%
-177.61M
42.41%
depreciation and amortization
571K
-
496K
13.13%
687K
38.51%
881K
28.24%
971K
10.22%
1.20M
24.00%
4.33M
259.63%
2.40M
44.57%
1.31M
45.46%
13.76M
951.03%
18.28M
32.88%
total other income expenses net
-2.43M
-
-432K
82.21%
-2.21M
411.57%
-1.50M
32.17%
-118K
92.13%
494K
518.64%
2.58M
421.86%
-45.30M
1,857.25%
4.84M
110.69%
26.66M
450.59%
16.68M
37.43%
income before tax
-20.89M
-
-25.88M
23.88%
-29.99M
15.88%
-33.46M
11.57%
-42.95M
28.36%
-66.60M
55.05%
-98.15M
47.38%
-173.39M
76.66%
-212.15M
22.36%
-281.72M
32.79%
-160.93M
42.88%
income tax expense
796K
-
53K
93.34%
-677K
1,377.36%
-743K
9.75%
297K
139.97%
2.19M
637.37%
-441K
120.14%
-3.09M
600%
-5.85M
89.50%
-26.66M
355.81%
net income
-20.89M
-
-25.88M
23.88%
-29.99M
15.88%
-33.46M
11.57%
-42.95M
28.36%
-66.60M
55.05%
-97.71M
46.71%
-170.30M
74.29%
-206.30M
21.14%
-255.06M
23.63%
-160.93M
36.90%
weighted average shs out
5.90M
-
20.45M
246.87%
25.48M
24.61%
31.75M
24.60%
41.98M
32.21%
56.20M
33.86%
68.19M
21.35%
82.39M
20.82%
94.75M
15.01%
96.83M
2.19%
98.41M
1.64%
weighted average shs out dil
5.90M
-
20.45M
246.87%
25.48M
24.61%
31.75M
24.60%
41.98M
32.21%
56.20M
33.86%
68.19M
21.35%
82.39M
20.82%
94.75M
15.01%
96.83M
2.19%
98.41M
1.64%
eps
-3.54
-
-1.27
64.12%
-1.18
7.09%
-1.05
11.02%
-1.02
2.86%
-1.19
16.67%
-1.43
20.17%
-2.07
44.76%
-2.18
5.31%
-2.63
20.64%
-1.64
37.64%
epsdiluted
-3.54
-
-1.27
64.12%
-1.18
7.09%
-1.05
11.02%
-1.02
2.86%
-1.19
16.67%
-1.43
20.17%
-2.07
44.76%
-2.18
5.31%
-2.63
20.64%
-1.64
37.64%

All numbers in USD (except ratios and percentages)